Biogen to cut 1,000 jobs as focus turns to Alzheimer's drug Leqembi launch

Biogen said it expects to eliminate roughly 1,000 positions to save money ahead of launching a new drug to treat Alzheimer's ... to focus on more lucrative options including the Leqembi launch ... Read More

Biogen gears up for Alzheimer's drug launch

Biogen CEO Michel Vounatsos Cited by Reuters, Vounatsos said: “We are actively preparing for the potential launch of aducanumab with an initial focus ... drug. Any new drug for Alzheimer's ... Read More

CHMP minded to turn down Alzheimer's drug Aduhelm, says Biogen

Biogen and Eisai have said that the EMA's human medicines committee looks unlikely recommended approval of their Alzheimer's drug Aduhelm when it comes up for discussion next month. Read More

Biogen, Eisai launch Alzheimer's drug Leqembi in China

Biogen (NASDAQ:BIIB) and its Japanese partner Eisai’s (OTCPK:ESALF) (OTCPK:ESAIY) breakthrough Alzheimer's therapy, Leqembi (lecanemab), is now available in China, the companies announced late ... Read More

Eisai expects 1,500 Alzheimer’s patients in China launch, sees ‘huge’ growth

CHICAGO/SHANGHAI--Japan’s Eisai aims to roll out its groundbreaking Alzheimer’s drug Leqembi ... China approved Leqembi in January. Eisai and U.S. partner Biogen have already rolled out ... Read More

Biogen Stock Slumps On Report of Death in Alzheimer's Drug Trial

Science.org reported Sunday that a woman participating in the joint Biogen-Eisai Clarity ... treatment with Aduhelm -- Biogen's FDA-approved Alzheimer's drug -- if patients are enrolled in a ... Read More

Biogen Stock Jumps On Positive Data From Aduhelm Alzheimer’s Drug Trial

said the drug "significantly" lowered blood levels in abnormal tau proteins, which are linked to neuronal damage in neurodegeneration, including Alzheimer's disease. Aduhelm, Biogen noted in ... Read More

EU regulator rejects Biogen’s Alzheimer’s drug

The European Union's drug regulator on Friday rejected Biogen Inc's controversial Alzheimer's drug ... fell 4.2% in premarket trading on the news. Biogen said in a statement it would seek a ... Read More

Biogen says uptake on new Alzheimer’s drug slower than expected

Biogen had previously ... ready to administer the drug shortly after its launch.(AP) Biogen Inc on Thursday said getting hospitals and clinics to use its new Alzheimer's disease drug Aduhelm ... Read More

Eisai and Biogen launch Alzheimer's drug Leqembi in China

(Reuters) - Eisai and Biogen have launched their Alzheimer's treatment Leqembi in China ... brain-wasting disease. The drug will first be launched in the private market at 2,508 yuan ($345. ... Read More